ViralClear Pharmaceuticals partners with Albany Molecular Research Inc. on the manufacture of merimepodib active pharmaceutical ingredient development for the potential treatment of COVID-19 Nasdaq:BSGM

Press/Media: Expert Comment

PeriodJul 8 2020

Media coverage

2

Media coverage

  • TitleViralClear Pharmaceuticals partners with Albany Molecular Research Inc. on the manufacture of merimepodib active pharmaceutical ingredient development for the potential treatment of COVID-19 Nasdaq:BSGM
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    CountryJordan
    Date7/8/20
    PersonsSlobodan Paessler, John Manning, Cheng Huang
  • TitleViralClear Pharmaceuticals partners with Albany Molecular Research Inc. on the manufacture of merimepodib active pharmaceutical ingredient development for the potential treatment of COVID-19 Nasdaq:BSGM
    Media name/outletFirstWord Pharma
    CountryUnited States
    Date7/8/20
    URLct.moreover.com/?a=42551113798&p=1gw&v=1&x=6I4Mi0oz6chBexf-MP0GTw
    PersonsSlobodan Paessler, John Manning, Cheng Huang

Keywords

  • COVID-19